SharpMed

SharpMed

Early Stage

Delivering the advanced, cost-effective medical devices hospitals need

Delivering the advanced, cost-effective medical devices hospitals need

Overview

Raised this Round: Raised: $161,928

Total Commitments ($USD)

Platform

Republic

Start Date

05/22/2024

Close Date

09/19/2024

Min. Goal
$50,000
Max. Goal
$1,200,000
Min. Investment

$100

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.00

Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

Scottsdale, Arizona

SharpMed is raising funds on Republic. The company makes transformative medical devices and delivers advanced and cost-effective medical devices to hospitals. SharpMed’s flagship product, Turbo O2 Cap, has FDA Class 1 clearance and will work as a lifeline in critical moments by preventing dangerous drops in oxygen levels during intubation. The product of SharpMed is 95% ready and is ready for its commercial launch in 2024. Dr. Chris Salvino founded SharpMed in December 2015. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1.2 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,041,555

$-2,702,404

Summary Balance Sheet

FY 2023 FY 2022

Cash

$73,268

$21,882

Accounts Receivable

$0

$0

Total Assets

$312,773

$531,945

Short-Term Debt

$3,846,594

$3,439,211

Long-Term Debt

$2,436,533

$2,436,533

Total Liabilities

$6,283,127

$5,875,744

Financials as of: 05/22/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
SharpMed on Republic 2024
Platform: Republic
Security Type: Equity - Common
Price per Share: $2.00

Follow company

Follow SharpMed on Republic 2024

Buy SharpMed's Deal Report

SharpMed Deal Report

Get KingsCrowd’s comprehensive report on SharpMed including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether SharpMed is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the SharpMed deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge